Study of cervical large cell neuroendocrine carcinoma
Part of Cancer, Women’s health & pregnancy clinical trials.
This study follows people diagnosed with a rare type of cervical cancer called large cell neuroendocrine carcinoma. Researchers want to learn more about how this cancer behaves and how patients respond to treatment over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with cervical large cell neuroendocrine carcinoma (a rare type of cervical cancer) through a tissue sample (biopsy or surgery).
- Your tumor must have certain features seen under a microscope, like large cells, fast growth (high mitotic rate), and specific growth patterns.
- Your tumor should not contain any other types of cancer cells (like squamous or adenocarcinoma).
- You must have follow-up information available and not have been lost to contact.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with cervical cancer that has not been treated before. It looks at how well a specific treatment works.
This study builds a registry (a secure database) of people who have had cervical neuroendocrine cancer, including small cell or large cell types. It helps researchers learn more about these cancers and may improve future care and research planning.
This study looks at the proteins in cervical neuroendocrine tumors to understand how they behave and how they affect long-term outcomes. It aims to find new markers that could help predict prognosis and guide treatment.
This study looks at how people with certain neuroendocrine cancers (including small cell lung cancer and large-cell neuroendocrine carcinoma) are diagnosed and treated in Latin America. It aims to understand the patient journey and improve future care.
This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.
This trial tests whether additional therapy after surgery can help people with a rare type of cervical cancer called gastric-type adenocarcinoma. It aims to find better ways to keep the cancer from coming back for those who have certain risk factors.
Hear when a new Uterine Cervical Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.